Modulating the polarization phenotype of microglia - a valuable strategy for central nervous system diseases

Ageing Res Rev. 2023 Dec 6:102160. doi: 10.1016/j.arr.2023.102160. Online ahead of print.ABSTRACTCentral nervous system (CNS) diseases have become one of the leading causes of death in the global population. The pathogenesis of CNS diseases is complicated, so it is important to find the patterns of the disease to improve the treatment strategy. Microglia are considered to be a double-edged sword, playing both harmful and beneficial roles in CNS diseases. Therefore, it is crucial to understand the progression of the disease and the changes in the polar phenotype of microglia to provide guidance in the treatment of CNS diseases. Microglia activation may evolve into different phenotypes: M1 and M2 types. We focused on the roles that M1 and M2 microglia play in regulating intercellular dialogues, pathological reactions and specific diseases in CNS diseases. Importantly, we summarized the strategies used to modulate the polarization phenotype of microglia, including traditional pharmacological modulation, biological therapies, and physical strategies. This review will contribute to the development of potential strategies to modulate microglia polarization phenotypes and provide new alternative therapies for CNS diseases.PMID:38065225 | DOI:10.1016/j.arr.2023.102160
Source: Ageing Research Reviews - Category: Genetics & Stem Cells Authors: Source Type: research